CY1108369T1 - Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων - Google Patents

Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων

Info

Publication number
CY1108369T1
CY1108369T1 CY20081101047T CY081101047T CY1108369T1 CY 1108369 T1 CY1108369 T1 CY 1108369T1 CY 20081101047 T CY20081101047 T CY 20081101047T CY 081101047 T CY081101047 T CY 081101047T CY 1108369 T1 CY1108369 T1 CY 1108369T1
Authority
CY
Cyprus
Prior art keywords
particles
health
therapeutic
ray
preparation
Prior art date
Application number
CY20081101047T
Other languages
English (en)
Inventor
Laurent Levy
Jean-François Hochepied
Jérémy Balencie
Paras Nath Prasad
Earl Jim Bergey
Edouard André Panak
Abdel Kader Boussaha
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of CY1108369T1 publication Critical patent/CY1108369T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε νέα ενεργοποιήσιμα σωματίδια που μπορούν να χρησιμοποιηθούν στον τομέα της υγείας. Η εφεύρεση αναφέρεται κυρίως σε σύνθετα σωματίδια ικανά να παράγουν ελεύθερες ρίζες ή θερμότητα υπό την επίδραση ακτινών Χ και στις χρήσεις τους στον τομέα της υγείας, κυρίως της ανθρώπινης υγείας. Τα σωματίδια της εφεύρεσης περιλαμβάνουν έναν πυρήνα που έχει ως βάση ανόργανες ενώσεις και, ενδεχομένως, οργανικές, και μπορούν να ενεργοποιούνται in vivo, για την ιχνηθεσία ή την αλλοίωση κυττάρων, ιστών ή οργάνων. Η εφεύρεση αφορά επίσης μεθόδους παραγωγής τέτοιων σωματιδίων, καθώς και φαρμακευτικές ή διαγνωστικές συνθέσεις που τα περιέχουν.
CY20081101047T 2004-05-10 2008-09-24 Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων CY1108369T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0405036A FR2869803B1 (fr) 2004-05-10 2004-05-10 Particules activables, preparation et utilisations
EP05769516A EP1744789B1 (fr) 2004-05-10 2005-05-09 Particules activables par des rayons x et/ou uv, leur preparation et leur utilisation thérapeutique ou diagnostique

Publications (1)

Publication Number Publication Date
CY1108369T1 true CY1108369T1 (el) 2014-02-12

Family

ID=34945762

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101047T CY1108369T1 (el) 2004-05-10 2008-09-24 Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων

Country Status (25)

Country Link
US (2) US9162079B2 (el)
EP (1) EP1744789B1 (el)
JP (1) JP5150251B2 (el)
KR (2) KR101234334B1 (el)
CN (1) CN100592921C (el)
AT (1) ATE403444T1 (el)
AU (1) AU2005251499B2 (el)
BR (1) BRPI0510290B8 (el)
CA (1) CA2564197C (el)
CY (1) CY1108369T1 (el)
DE (1) DE602005008731D1 (el)
DK (1) DK1744789T3 (el)
EA (1) EA010246B1 (el)
ES (1) ES2312004T3 (el)
FR (1) FR2869803B1 (el)
HK (1) HK1099508A1 (el)
HR (1) HRP20080534T3 (el)
IL (1) IL178877A (el)
MX (1) MXPA06013095A (el)
PL (1) PL1744789T3 (el)
PT (1) PT1744789E (el)
RS (1) RS50615B (el)
SI (1) SI1744789T1 (el)
WO (1) WO2005120590A1 (el)
ZA (1) ZA200610255B (el)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867180B1 (fr) 2004-03-02 2006-06-16 Univ Claude Bernard Lyon Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
FR2877571B1 (fr) * 2004-11-05 2007-04-13 Nanobiotix Sarl Nanoparticules pourvues d'un element de ciblage intracellulaire, preparation et utilisations
JP4998888B2 (ja) * 2004-11-15 2012-08-15 オーストラリアン ニュークリア サイエンス アンド テクノロジー オーガニゼーション マイクロエマルジョンの制御された不安定化からの固体粒子
US20070218049A1 (en) * 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
EP2000150B1 (en) * 2006-03-24 2016-07-13 Toto Ltd. Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
EP1852107A1 (en) * 2006-04-19 2007-11-07 Nanobiotix Magnetic nanoparticles compositions and uses thereof
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging
US9488916B2 (en) 2007-04-08 2016-11-08 Immunolight, Llc. Interior energy-activation of photo-reactive species inside a medium or body
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US8376013B2 (en) 2008-03-11 2013-02-19 Duke University Plasmonic assisted systems and methods for interior energy-activation from an exterior source
FR2922106B1 (fr) * 2007-10-16 2011-07-01 Univ Claude Bernard Lyon Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
US8529426B2 (en) * 2007-10-18 2013-09-10 The Invention Science Fund I Llc Ionizing-radiation-responsive compositions, methods, and systems
US8227204B2 (en) * 2007-10-18 2012-07-24 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
US9557635B2 (en) * 2007-10-18 2017-01-31 Gearbox, Llc Ionizing-radiation-responsive compositions, methods, and systems
US8164074B2 (en) * 2007-10-18 2012-04-24 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
US20090104113A1 (en) * 2007-10-18 2009-04-23 Searete Llc Ionizing-radiation-responsive compositions, methods, and systems
GB2453860B (en) * 2007-10-18 2011-03-16 Searete Llc Ionizing-radiation-responsive compositions,methods and systems
US8168958B2 (en) * 2007-10-18 2012-05-01 The Invention Science Fund I, Llc Ionizing-radiation-responsive compositions, methods, and systems
US8684898B2 (en) * 2007-10-18 2014-04-01 The Invention Science Fund I Llc Ionizing-radiation-responsive compositions, methods, and systems
AR070461A1 (es) 2008-02-21 2010-04-07 Immunolight Llc Metodos y sistemas para tratar trastornos de proliferacion celular usando terapia fotoespectral mejorada con plasmonicos (pepst) y fototerapia mejorada con excitones plasmones (epep). composiciones.
US9907976B2 (en) 2011-07-08 2018-03-06 Immunolight, Llc Phosphors and scintillators for light stimulation within a medium
EP3300744A1 (en) * 2008-04-04 2018-04-04 Immunolight, Llc. Non-invasive systems and methods for in-situ photobiomodulation
EP2130553A1 (en) * 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
US8770203B2 (en) 2008-07-14 2014-07-08 Immunolight, Llc. Advanced methods and systems for treating cell proliferation disorders
WO2010013136A2 (en) 2008-07-31 2010-02-04 Alma Mater Studiorum - Universita' Di Bologna Active particles for bio-analytical applications and methods for their preparation
SA114350273B1 (ar) * 2009-04-21 2016-06-23 امونولايت، ال ال سي أنظمة وطرق غير انتشارية للتحويل العلوي للطاقة للتعديل الحيوي الضوئي في الموقع
CN102870235B (zh) 2009-11-10 2016-11-23 免疫之光有限责任公司 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统
GB0921596D0 (en) 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
PT2567257T (pt) 2010-05-06 2021-07-20 Immunolight Llc Composição de ligação adesiva e método de utilização
PL3222266T3 (pl) 2010-08-27 2018-10-31 Sienna Biopharmaceuticals, Inc. Kompozycje i sposoby do termomodulacji celowanej
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
US9116246B2 (en) * 2011-04-07 2015-08-25 Stc.Unm Thermal neutron detectors based on gadolinium-containing nanoscintillators
JPWO2012153820A1 (ja) * 2011-05-12 2014-07-31 コニカミノルタ株式会社 Ｘ線吸収蛍光ナノ粒子
US9693957B2 (en) 2011-07-08 2017-07-04 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
WO2013035739A1 (ja) * 2011-09-05 2013-03-14 株式会社Ihi 温熱治療用材料、温熱治療用システム及び温熱治療方法
JP6042450B2 (ja) 2011-12-16 2016-12-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
IL305614B1 (en) 2012-10-11 2024-05-01 Nanocomposix Inc Compositions of silver nanoparticle coating and methods
SI3010552T1 (sl) * 2013-06-20 2019-08-30 Nanobiotix Sestavki za uporabo v onkologiji
JP6560665B2 (ja) * 2013-06-20 2019-08-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 医療診断に使用するための組成物および方法
FR3018451A1 (fr) 2014-03-13 2015-09-18 Chromalys Nanoparticules pour leur utilisation dans la detection de tumeurs mobiles
WO2015149188A1 (en) * 2014-04-03 2015-10-08 The Governing Council Of The University Of Toronto Multifunctional nanoparticle compositions and uses thereof
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
US10206871B2 (en) 2014-10-14 2019-02-19 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, chemotherapy, immunotherapy, and any combination thereof
WO2016112314A1 (en) * 2015-01-08 2016-07-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
CN107708668A (zh) 2015-05-28 2018-02-16 纳米生物技术公司 用作治疗性疫苗的纳米粒子
US9770688B2 (en) * 2015-10-22 2017-09-26 King Fahd University Of Petroleum And Minerals Si—Y nanocomposite membrane and methods of making and use thereof
CN109310702A (zh) 2016-05-20 2019-02-05 芝加哥大学 用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒
CN110382010A (zh) 2016-12-08 2019-10-25 布里格姆妇女医院 铋-钆纳米颗粒
US10283476B2 (en) 2017-03-15 2019-05-07 Immunolight, Llc. Adhesive bonding composition and electronic components prepared from the same
CN111194232B (zh) 2017-08-02 2023-01-31 芝加哥大学 纳米级金属有机层和金属有机纳米片
EP3849613A2 (en) 2018-06-01 2021-07-21 Tae Life Sciences Biodegradable nanocarriers for neutron capture therapy and methods thereof
CN116615269A (zh) * 2020-12-01 2023-08-18 纳米生物技术公司 作为辐射增强剂的多孔、高z和无碳颗粒
CN112655715A (zh) * 2020-12-25 2021-04-16 杭州甜蜜按钮科技有限公司 一种哺乳期羊舍专用消毒剂的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985173A (en) * 1997-11-18 1999-11-16 Gray; Henry F. Phosphors having a semiconductor host surrounded by a shell
JP3490015B2 (ja) * 1999-03-11 2004-01-26 関西ティー・エル・オー株式会社 化学的耐久性に優れた放射性微小球及びその製造方法
EP1263447B1 (en) * 2000-02-08 2013-06-26 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU5835801A (en) * 2000-05-05 2001-11-20 Bayer Ag Doped nanoparticles as biolabels
US20020127224A1 (en) * 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
CN1893976A (zh) * 2003-12-17 2007-01-10 皇家飞利浦电子股份有限公司 使用uv发射纳米微粒的放射治疗和医学成像
WO2005107818A2 (en) * 2004-04-30 2005-11-17 University Of Florida Nanoparticles and their use for multifunctional bioimaging
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070218049A1 (en) * 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same

Also Published As

Publication number Publication date
BRPI0510290A8 (pt) 2019-01-02
DE602005008731D1 (de) 2008-09-18
AU2005251499A1 (en) 2005-12-22
KR101234334B1 (ko) 2013-02-18
BRPI0510290B8 (pt) 2021-10-19
MXPA06013095A (es) 2007-04-27
RS50615B (sr) 2010-06-30
CA2564197A1 (fr) 2005-12-22
ES2312004T3 (es) 2009-02-16
CA2564197C (fr) 2013-05-07
CN100592921C (zh) 2010-03-03
IL178877A0 (en) 2007-03-08
US9162079B2 (en) 2015-10-20
AU2005251499B2 (en) 2010-06-10
JP5150251B2 (ja) 2013-02-20
HRP20080534T3 (en) 2008-11-30
HK1099508A1 (en) 2007-08-17
BRPI0510290A (pt) 2007-10-30
JP2007536356A (ja) 2007-12-13
US9433800B2 (en) 2016-09-06
US20150238775A1 (en) 2015-08-27
CN1950111A (zh) 2007-04-18
BRPI0510290B1 (pt) 2021-06-01
KR20070014172A (ko) 2007-01-31
WO2005120590A1 (fr) 2005-12-22
KR20120123731A (ko) 2012-11-09
PL1744789T3 (pl) 2009-01-30
DK1744789T3 (da) 2008-12-08
FR2869803A1 (fr) 2005-11-11
PT1744789E (pt) 2008-11-04
US20070217996A1 (en) 2007-09-20
ATE403444T1 (de) 2008-08-15
EP1744789B1 (fr) 2008-08-06
IL178877A (en) 2010-12-30
EA010246B1 (ru) 2008-06-30
EA200602077A1 (ru) 2007-04-27
FR2869803B1 (fr) 2006-07-28
EP1744789A1 (fr) 2007-01-24
SI1744789T1 (sl) 2008-10-31
ZA200610255B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
CY1108369T1 (el) Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
CY1120670T1 (el) Μονοκλωνικα αντισωματα εναντι του αναστολεα μονοπατιου ιστικου παραγοντα (tfpi)
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
CY1114272T1 (el) Υποκατεστημενες διυδροπυραζολονες για την θεραπευτικη αντιμετωπιση των καρδιαγγειακων και αιματολογικων παθησεων
EA201791669A2 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
CY1111065T1 (el) Φαρμακευτικη συνθεση που περιεχει μια ωμεγα-καρβοξυαρυλ υποκατεστημενη διφαινυλ ουρια για τη θεραπευτικη αντιμετωπιση του καρκινου
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
CY1113136T1 (el) Αντιμετωπιση των διαταραχων των χονδρων με ton fgf-18
CY1117312T1 (el) Θεραπευτικη αγωγη συνουκλεϊνοπαθειων
CY1120536T1 (el) Μεθοδος και συνθεσεις για τη θεραπευτικη αγωγη του καρκινου
CY1115076T1 (el) ΕΝΑ ANTΙ-PDGFRα ΑΝΤΙΣΩΜΑ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΜΕΤΑΣΤΑΤΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΩΝ ΟΣΤΩΝ
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
CY1106259T1 (el) Συνδυασμενη θepαπεια που πepιλαμβανει zd6474 κι ενα ταξανιο
CY1115316T1 (el) Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων
UY32092A (es) Nuevos compuestos para el tratamiento de trastornos del snc
CY1112724T1 (el) Παραγωγα ανθρακικης κουινουκλιδινης και ιατρικη συνθεση αυτων
BR112015001782A2 (pt) método para produzir uma composição para o tratamento de um dente lesionado
BRPI0516626A (pt) pteridinas substituìdas e uso das mesmas
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
CY1115734T1 (el) Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη
CY1114366T1 (el) Συνθεσεις που περιεχουν αποαικoυορiνη και μεθοδοι χρησης τους
CY1115987T1 (el) Θεραπευτικες εφαρμογες στον καρδιαγγειακο τομεα των παραγωγων κιναζολινεδιονης
PA8626001A1 (es) Derivados radiohalogenados de benzamida y su uso en el diagnóstico y la terapia de tumores
Tsanova et al. Clinical evaluation of CAD/CAM indirect zirconia restorations of severely destroyed vital teeth in the posterior area–early clinical results